PharmaBlock Sciences Nanjing Inc Class A (300725) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, PharmaBlock Sciences Nanjing Inc Class A (300725) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥83.36 Million ≈ $12.20 Million USD) by net assets (CN¥7.15 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PharmaBlock Sciences Nanjing Inc Class A stock valuation for the company's overall valuation and market capitalisation.

PharmaBlock Sciences Nanjing Inc Class A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how PharmaBlock Sciences Nanjing Inc Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PharmaBlock Sciences Nanjing Inc Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmaBlock Sciences Nanjing Inc Class A ranked by their cash flow conversion efficiency. Explore earnings quality score of PharmaBlock Sciences Nanjing Inc Class A to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Vanchip (Tianjin) Technology Co. Ltd. A SHG:688153	N/A
Immunocore Holdings Ltd NASDAQ:IMCR	-0.011x
CITIC Guoan Information Industry Co Ltd SHE:000839	0.055x
Foreign Trade Bank of Latin America Inc NYSE:BLX	0.030x
Shandong Fiberglass Group Co Ltd SHG:605006	-0.042x
nCino Inc NASDAQ:NCNO	0.083x
Deterra Royalties Ltd AU:DRR	0.623x
Shenzhen Changhong Tech SHE:300151	0.045x

Annual Cash Flow Conversion Efficiency for PharmaBlock Sciences Nanjing Inc Class A (2013–2025)

The table below shows the annual cash flow conversion efficiency of PharmaBlock Sciences Nanjing Inc Class A from 2013 to 2025. View PharmaBlock Sciences Nanjing Inc Class A (300725) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.30 Billion ≈ $921.91 Million	CN¥667.36 Million ≈ $97.66 Million	0.106x	+4.51%
2024-12-31	CN¥2.99 Billion ≈ $437.17 Million	CN¥302.82 Million ≈ $44.31 Million	0.101x	+16.30%
2023-12-31	CN¥2.83 Billion ≈ $414.45 Million	CN¥246.84 Million ≈ $36.12 Million	0.087x	-6.08%
2022-12-31	CN¥2.66 Billion ≈ $388.90 Million	CN¥246.61 Million ≈ $36.09 Million	0.093x	+2.44%
2021-12-31	CN¥2.63 Billion ≈ $384.52 Million	CN¥238.03 Million ≈ $34.83 Million	0.091x	-36.79%
2020-12-31	CN¥1.89 Billion ≈ $277.26 Million	CN¥271.51 Million ≈ $39.73 Million	0.143x	-16.44%
2019-12-31	CN¥740.87 Million ≈ $108.41 Million	CN¥127.04 Million ≈ $18.59 Million	0.171x	-35.79%
2018-12-31	CN¥599.73 Million ≈ $87.76 Million	CN¥160.16 Million ≈ $23.44 Million	0.267x	+146.14%
2017-12-31	CN¥503.59 Million ≈ $73.69 Million	CN¥54.64 Million ≈ $8.00 Million	0.108x	+21.17%
2016-12-31	CN¥254.15 Million ≈ $37.19 Million	CN¥22.76 Million ≈ $3.33 Million	0.090x	-52.32%
2015-12-31	CN¥146.56 Million ≈ $21.45 Million	CN¥27.52 Million ≈ $4.03 Million	0.188x	+37.48%
2014-12-31	CN¥87.18 Million ≈ $12.76 Million	CN¥11.91 Million ≈ $1.74 Million	0.137x	-47.68%
2013-12-31	CN¥70.16 Million ≈ $10.27 Million	CN¥18.32 Million ≈ $2.68 Million	0.261x	--

About PharmaBlock Sciences Nanjing Inc Class A

SHE:300725 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.62 Billion

CN¥11.04 Billion CNY

Market Cap Rank

#6983 Global

#1470 in China

Share Price

CN¥47.22

Change (1 day)

+1.97%

52-Week Range

CN¥31.25 - CN¥54.79

All Time High

CN¥246692.27